NYSEARCA:SBIO

Alps Medical Breakthroughs Etf Alps Medical Breakthroughs Etf ETF News

etoro logo Buy SBIO
*Your capital is at risk
$65.28
-1.94 (-2.89%)
At Close: Jul 13, 2026
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the ALPS Medical Breakthroughs ETF (SBIO) is a passively managed exchange traded fund launched on December 31
ALPS Medical Breakthroughs ETF targets late-stage clinical trial biotechs primed for outsized performance and M&A. SBIO's selective criteria focus on U.S.-listed firms with strong cash positions, Phas

Biotech Gives SBIO Its Best Month Since 2023

01:24pm, Thursday, 02'nd Jul 2026
Biotech stocks delivered their best single month since late 2023 in June, carrying the ALPS Medical Breakthroughs ETF (SBIO) to one of the top returns across the ALPS lineup. Key Takeaways: SBIO retur
June has been a month full of excitement in the ETF market. While commercial space and AI infrastructure attracted a significant amount of investor attention, biotechnology exposure comprises four out

Biotech ETF Index Surges 10% After Rebalance

11:31am, Thursday, 25'th Jun 2026
After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs ETF (SBIO) gained over 10% in just six trading days beginning June 18. Key Takeaways: SBIO's underly
The biotechnology sector has broken out of its multiyear bear market. As macroeconomic headwinds moderate and regulatory environments stabilize, biotech ETFs are surging.
NichLmao, Peet Montzingo, DangMattSmith, Merrick Hanna and more to compete in a 16-player tournament produced by Creator TV®, set to premiere on streaming this summer. LOS ANGELES, June 15, 2026 /PRN
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
Sabio Holdings Inc. (SBIO:CA) Q1 2026 Earnings Call Transcript
Produced series marks the Creator Poker Championship's transition from livestream to television. TORONTO, May 12, 2026 /PRNewswire/ -- Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF) (the "Company" or "Sab
Sabio Holdings Inc. (SBIO:CA) Q4 2025 Earnings Call Transcript
The leading articles for last week ran the gamut in terms of topics, but suggest investors are still worried about inflation and remain interested in biotech, nuclear energy, and derivatives strategie
ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ou

This Biotech ETF's Hot Start Can Continue

12:29pm, Monday, 20'th Apr 2026
Broader healthcare ETFs aren't doing much to appease investors this year, but biotech funds are warding off that weakness. Just look at the ALPS Medical Breakthroughs ETF (SBIO).
While some investment themes have struggled to maintain their trajectory, the space economy has proven it has the fundamental fuel to reach escape velocity. This momentum is being met with a strategic
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE